Negative Charge-Carrying Glycans Attached to Exosomes as Novel Liquid Biopsy Marker
Natalia Kosutova,Lenka Lorencova,Michal Hires,Eduard Jane,Lubomir Orovcik,Jozef Kollar,Katarina Kozics,Alena Gabelova,Egor Ukraintsev,Bohuslav Rezek,Peter Kasak,Hana Cernocka,Veronika Ostatna,Jana Blahutova,Alica Vikartovska,Tomas Bertok,Jan Tkac
DOI: https://doi.org/10.3390/s24041128
IF: 3.9
2024-02-09
Sensors
Abstract:Prostate cancer (PCa) is the second most common cancer. In this paper, the isolation and properties of exosomes as potential novel liquid biopsy markers for early PCa liquid biopsy diagnosis are investigated using two prostate human cell lines, i.e., benign (control) cell line RWPE1 and carcinoma cell line 22Rv1. Exosomes produced by both cell lines are characterised by various methods including nanoparticle-tracking analysis, dynamic light scattering, scanning electron microscopy and atomic force microscopy. In addition, surface plasmon resonance (SPR) is used to study three different receptors on the exosomal surface (CD63, CD81 and prostate-specific membrane antigen-PMSA), implementing monoclonal antibodies and identifying the type of glycans present on the surface of exosomes using lectins (glycan-recognising proteins). Electrochemical analysis is used to understand the interfacial properties of exosomes. The results indicate that cancerous exosomes are smaller, are produced at higher concentrations, and exhibit more nega tive zeta potential than the control exosomes. The SPR experiments confirm that negatively charged α-2,3- and α-2,6-sialic acid-containing glycans are found in greater abundance on carcinoma exosomes, whereas bisecting and branched glycans are more abundant in the control exosomes. The SPR results also show that a sandwich antibody/exosomes/lectins configuration could be constructed for effective glycoprofiling of exosomes as a novel liquid biopsy marker.
engineering, electrical & electronic,chemistry, analytical,instruments & instrumentation